Evidence map›Paper›PMID 32949145›Full record

ArticleJournal of the American Geriatrics Society2020

D-CARE: The Dementia Care Study: Design of a Pragmatic Trial of the Effectiveness and Cost Effectiveness of Health System-Based Versus Community-Based Dementia Care Versus Usual Dementia Care.

David B Reuben, Thomas M Gill, Alan Stevens, Jeff Williamson, Elena Volpi, Maya Lichtenstein, Lee A Jennings, Zaldy Tan, Leslie Evertson, David Bass and 25 more

Erratum issuedAbstract readClinical Trial Protocol
In one paragraph

Article in Journal of the American Geriatrics Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Guideline
  2. Guideline
  3. Correlates and predictors of self-efficacy among dementia caregivers: D-CARE findings.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Participation of persons with dementia and their caregivers in research.Journal of the American Geriatrics Society · 2021
    Review
  17. Alzheimer disease.Nature reviews. Disease primers · 2021
    Review
  18. Aducanumab: Appropriate Use Recommendations.The journal of prevention of Alzheimer's disease · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

35 authors.

David B ReubenDepartment of Medicine, Division of Geriatrics, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.ORCID 0000-0002-1363-4745
Thomas M GillDepartment of Internal Medicine, Section of Geriatrics, Yale University, New Haven, Connecticut, USA.ORCID 0000-0002-6450-0368
Alan StevensDepartment of Medicine, Baylor Scott & White Health, Temple, Texas, USA.
Jeff WilliamsonDepartment of Internal Medicine, Section on Gerontology and Geriatric Medicine, Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, USA.
Elena VolpiDepartment of Internal Medicine, Division of Geriatrics, University of Texas, Medical Branch, Galveston, Texas, USA.
Maya LichtensteinDepartment of Neurology, Geisinger Health, Wilkes Barre, Pennsylvania, USA.ORCID 0000-0001-6270-575X
Lee A JenningsDepartment of Medicien, Reynolds Section of Geriatrics, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.ORCID 0000-0002-9524-6921
Zaldy TanDepartment of Medicine, Division of Geriatrics, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Leslie EvertsonDepartment of Medicine, Division of Geriatrics, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
David BassCenter for Research and Education, Benjamin Rose Institute on Aging, Cleveland, Ohio, USA.
Lisa WeitzmanCenter for Research and Education, Benjamin Rose Institute on Aging, Cleveland, Ohio, USA.
Martie CarnieCenter for Patients and Families, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Nancy WilsonDepartment of Medicine, Baylor College of Medicine, Houston, Texas, USA.
Katy AraujoDepartment of Internal Medicine, Section of Geriatrics, Yale University, New Haven, Connecticut, USA.
Peter CharpentierDepartment of Internal Medicine, Section of Geriatrics, Yale University, New Haven, Connecticut, USA.
Can MengDepartment of Internal Medicine, Section of Geriatrics, Yale University, New Haven, Connecticut, USA.
Erich J GreeneDepartment of Internal Medicine, Section of Geriatrics, Yale University, New Haven, Connecticut, USA.ORCID 0000-0002-9473-830X
James DziuraDepartment of Internal Medicine, Section of Geriatrics, Yale University, New Haven, Connecticut, USA.
Jodi LiuPardee RAND Graduate School, Santa Monica, California, USA.
Erin UngerDepartment of Medicine, Division of Geriatrics, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Mia YangDepartment of Internal Medicine, Section on Gerontology and Geriatric Medicine, Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, USA.ORCID 0000-0002-5439-3706
Katherine CurrieDepartment of Internal Medicine, Section on Gerontology and Geriatric Medicine, Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, USA.
Kristin M LenoirDepartment of Internal Medicine, Section on Gerontology and Geriatric Medicine, Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, USA.
Aval-NaʼRee S GreenDepartment of Medicine, Baylor Scott & White Health, Temple, Texas, USA.
Sitara AbrahamDepartment of Medicine, Baylor Scott & White Health, Temple, Texas, USA.
Ashley VernonDepartment of Medicine, Baylor Scott & White Health, Temple, Texas, USA.
Rafael Samper-TernentDepartment of Internal Medicine, Division of Geriatrics, University of Texas, Medical Branch, Galveston, Texas, USA.
Mukaila RajiDepartment of Internal Medicine, Division of Geriatrics, University of Texas, Medical Branch, Galveston, Texas, USA.
Roxana M HirstDepartment of Internal Medicine, Division of Geriatrics, University of Texas, Medical Branch, Galveston, Texas, USA.
Rebecca GallowayDepartment of Internal Medicine, Division of Geriatrics, University of Texas, Medical Branch, Galveston, Texas, USA.
Glen R FinneyDepartment of Neurology, Geisinger Health, Wilkes Barre, Pennsylvania, USA.
Ilene LaddDepartment of Neurology, Geisinger Health, Wilkes Barre, Pennsylvania, USA.
Alanna Kulchak RahmDepartment of Neurology, Geisinger Health, Wilkes Barre, Pennsylvania, USA.
Pamela BorekDepartment of Neurology, Geisinger Health, Wilkes Barre, Pennsylvania, USA.
Peter PeduzziDepartment of Internal Medicine, Section of Geriatrics, Yale University, New Haven, Connecticut, USA.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
UTMB OAIC Research Education Component (REC)P30AG024832 · NIA · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI JAMES S. GOODWIN, MD, MELISSA M. MORROW · 2005 to 2026
$26.7M
Wake Forest Alzheimer's Disease Core CenterP30AG049638 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ESPELAND, MARK ANDREW · 2016 to 2020
$12.2M
Pragmatic Trial of the Effectiveness and Cost-Effectiveness of Dementia Care.R01AG061078 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI REUBEN, DAVID B. · 2018 to 2023
$8.4M
NCATS NIH HHS UL1 TR001863NIA NIH HHS P30 AG024832NIA NIH HHS P30 AG049638NIA NIH HHS R01 AG061078NIH HHSPatient-Centered Outcomes Research Institute PCS-2017C1-6534
6 · The paper itself

Abstract

BACKGROUND/

objectivesAlthough several approaches have been developed to provide comprehensive care for persons living with dementia (PWD) and their family or friend caregivers, the relative effectiveness and cost effectiveness of community-based dementia care (CBDC) versus health system-based dementia care (CBDC) and the effectiveness of both approaches compared with usual care (UC) are unknown.

designPragmatic randomized three-arm superiority trial. The unit of randomization is the PWD/caregiver dyad.

settingFour clinical trial sites (CTSs) based in academic and clinical health systems.

participantsA total of 2,150 English- or Spanish-speaking PWD who are not receiving hospice or residing in a nursing home and their caregivers.

interventionsEighteen months of (1) HSDC provided by a nurse practitioner or physician's assistant dementia care specialist who works within the health system, or (2) CBDC provided by a social worker or nurse care consultant who works at a community-based organization, or (3) UC with as needed referral to the Alzheimer's Association Helpline. MEASUREMENTS: Primary outcomes: PWD behavioral symptoms and caregiver distress as measured by the Neuropsychiatric Inventory Questionnaire (NPI-Q) Severity and Modified Caregiver Strain Index scales. SECONDARY OUTCOMES: NPI-Q Distress, caregiver unmet needs and confidence, and caregiver depressive symptoms. Tertiary outcomes: PWD long-term nursing home placement rates, caregiver-reported PWD functional status, cognition, goal attainment, "time spent at home," Dementia Burden Scale-Caregiver, a composite measure of clinical benefit, Quality of Life of persons with dementia, Positive Aspects of Caregiving, and cost effectiveness using intervention costs and Medicare claims.

resultsThe results will be reported in the spring of 2024.

conclusionD-CARE will address whether emphasis on clinical support and tighter integration with other medical services has greater benefit than emphasis on social support that is tied more closely to community resources. It will also assess the effectiveness of both interventions compared with UC and will evaluate the cost effectiveness of each intervention.

Indexed as

AgedAlzheimer DiseaseCaregiver BurdenCommunity Health ServicesComprehensive Health CareCost-Benefit AnalysisEquivalence Trials as TopicFemaleHumansMaleMulticenter Studies as TopicPragmatic Clinical Trials as TopicQuality ImprovementQuality of LifeAlzheimer's diseasecare coordinationdementiapragmatic trials

Identifiers

PMID32949145
PMCPMC8086629

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.